Nectar Lifesciences Limited Overview
Pro stress-test →Nectar Lifesciences is a leading global manufacturer of cephalosporin antibiotics medicines, serving over 45 countries. The company manufactures active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules.
Strategic Profile
Pro stress-test →Nectar Lifesciences is a research-driven manufacturer specializing in anti-infectives like cephalosporins and serves as a contract manufacturing organization (CMO) for global pharma innovators. The company operates large-scale manufacturing facilities near Chandigarh with approvals from multiple global regulatory bodies.
Competitive Landscape
Pro stress-test →Nectar Lifesciences competes in the cephalosporin API space against larger Indian pharma majors like Lupin, Aurobindo, and Cipla, as well as international players. The company's niche focus on cephalosporins and contract manufacturing provides differentiation but faces margin pressures from commodity-like pricing in the API segment. Weak financial performance has reduced competitive positioning.
Industry Context
Nectar Lifesciences Limited operates in Pharmaceutical Manufacturing (Active Pharmaceutical Ingredients & Formulations).
Key facts
Founded: 1995 · Headquarters: Chandigarh, India · Employees: 1,790 · Revenue: ₹16.70B · Market cap: ₹2.61B